VSIG2 and acute myeloid leukemia: It is worth noting that VSIG2 expression is positively associated with the development and poor prognosis of AML, primary lung adenocarcinoma, and PDAC, while VSIG2 suppresses muscle invasive bladder cancer as well as COAD [17, 22–25].